REMINDER
Sunday, July 30, 2006
Reminder - Next Meeting Friday, 8/4/06
Wednesday, July 26, 2006
Don't Ignore Early Signs of Arthritis
Rutland Herald, Vermont, CT
July 24, 2006
Dr. T. Glenn Pait, associate professor of neurosurgery and orthopedic surgery at the University of Arkansas for Medical Sciences and director of the Stephens Spine and Neurosciences Institute at UAMS, thinks that treatment for arthritis should be multipronged.
According to the Arthritis Foundation, more than 42 million Americans have been diagnosed with arthritis of some form; another 23.2 million people live with chronic joint symptoms but have not been diagnosed by a doctor.
Contrary to popular belief, arthritis isn't a disease that affects only older adults.More than half of the cases involve people younger than 65, including nearly 3 million children.
The term arthritis is used to describe more than 100 rheumatic diseases and conditions that affect joints, the tissues that surround the joint and other connective tissue.
The pattern, severity and location of symptoms can vary depending on the specific form of the disease. Some forms of arthritis include osteoarthritis, rheumatoid arthritis, gout, ankylosing spondylitis, juvenile arthritis, systemic lupus erythematosis, scleroderma and fibromyalgia.
Osteoarthritis is the most common form of arthritis, a chronic disease that causes a breakdown of the cushioning cartilage in joints and the formation of new bone at the margin of joints.
Read more ...
July 24, 2006
Dr. T. Glenn Pait, associate professor of neurosurgery and orthopedic surgery at the University of Arkansas for Medical Sciences and director of the Stephens Spine and Neurosciences Institute at UAMS, thinks that treatment for arthritis should be multipronged.
According to the Arthritis Foundation, more than 42 million Americans have been diagnosed with arthritis of some form; another 23.2 million people live with chronic joint symptoms but have not been diagnosed by a doctor.
Contrary to popular belief, arthritis isn't a disease that affects only older adults.More than half of the cases involve people younger than 65, including nearly 3 million children.
The term arthritis is used to describe more than 100 rheumatic diseases and conditions that affect joints, the tissues that surround the joint and other connective tissue.
The pattern, severity and location of symptoms can vary depending on the specific form of the disease. Some forms of arthritis include osteoarthritis, rheumatoid arthritis, gout, ankylosing spondylitis, juvenile arthritis, systemic lupus erythematosis, scleroderma and fibromyalgia.
Osteoarthritis is the most common form of arthritis, a chronic disease that causes a breakdown of the cushioning cartilage in joints and the formation of new bone at the margin of joints.
Read more ...
Monday, July 17, 2006
New Knees Designed for Women
Hundreds of thousands of knee replacement surgeries are done every year. About two-thirds of the patients are women and, until now, there was a gender gap in the OR.
Annie Beylerian is making medical history. She’s one of the first to receive a revolutionary new knee implant specifically designed for women. “I couldn't walk," she says.
Dr. Michael Kelly, who helped design the new “gender solutions” knee, says it's shaped more like a woman's natural knee.
He says, "Women have a little different makeup in their knee’s anatomy than men do. If we were to look at that, they’re a little bit taller and they are a little bit narrower.”
A traditional implant is often too wide for a woman. The result can be pain and decreased function. The new gender-specific implant is designed for a better fit.
Dr. Kelly says, "You can see a very nice contour here. There’s a little bit different angle in the way the kneecap slides in and a little bit smaller amount of metal here, all to keep the patella-femoral mechanics. Or in plain terms, how your kneecap functions when you go up and down the stairs, or arise from a seat or drive a car.”
Replacement knees have been available in different sizes for years. This time it's the shape that counts.
Dr. Kelly says, "We went to right and lefts, which became even better than the symmetric knees which was one size kind of fit all and you figure out surgically how to correct it. But now this is just one step further.”
Dr. Kelly says that, for the moment, the gender solutions knee comes in one size. By the end of summer, it should be available in several sizes. continue reading ...
Wednesday, July 05, 2006
Abatacept/Methotrexate Combo Reduces Progression of Rheumatoid Arthritis: Presented at EULAR
By Chris Berrie
AMSTERDAM, THE NETHERLANDS -- June 30, 2006 -- Patients with rheumatoid arthritis (RA) have a continual and increasing benefit effect when they are treated with the combination of abatacept and methotrexate (MTX), according to the open-label long-term extension of the randomised, double-blind Abatacept in Inadequate Responders to Methotrexate (AIM) study.
The findings of the (AIM-LTE) were presented here on June 23rd at the 2006 Annual European Congress of Rheumatology (EULAR) by principal investigator Harry Genant, MD, professor emeritus, department of radiology and medicine, University of California San Francisco, and chairman of the board of directors, Synarc, San Francisco, California, United States.
Abatacept, a selective co-stimulation modulator that targets T-cell activation, has been demonstrated to have efficacy in patients with active RA who have an inadequate response to disease-modifying antirheumatic drugs (DMARDs). Continue reading article ...
AMSTERDAM, THE NETHERLANDS -- June 30, 2006 -- Patients with rheumatoid arthritis (RA) have a continual and increasing benefit effect when they are treated with the combination of abatacept and methotrexate (MTX), according to the open-label long-term extension of the randomised, double-blind Abatacept in Inadequate Responders to Methotrexate (AIM) study.
The findings of the (AIM-LTE) were presented here on June 23rd at the 2006 Annual European Congress of Rheumatology (EULAR) by principal investigator Harry Genant, MD, professor emeritus, department of radiology and medicine, University of California San Francisco, and chairman of the board of directors, Synarc, San Francisco, California, United States.
Abatacept, a selective co-stimulation modulator that targets T-cell activation, has been demonstrated to have efficacy in patients with active RA who have an inadequate response to disease-modifying antirheumatic drugs (DMARDs). Continue reading article ...
Saturday, July 01, 2006
REMINDER: Next ASG-SLC Meeting, 7/7, Friday
REMINDER for Arthritis Support Group Members
ARTHRITIS SUPPORT GROUP MEETING OF SOUTH LAKE COUNTY - Welcome individuals affected by Arthritis, family members, friends, and anyone interested. Free brochures and literature available. We meet the 1st Friday of each month at the National Training Center, Clermont. The meeting starts 12:00-1:30 PM. Fee: FREE. Bring your sweater, lunch, or snacks to share if you want. For more information call Meg King at 352-243-2098.
______________________________________________________
NEXT MEETING - July 7th, Friday
Guest Speaker: Deanna Cuevas, L.M.T., from Total Family Health Care in Clermont. Topic: “Massage Your Cares Away” Massage Therapy; a Viable Treatment for Arthritis.
Subscribe to:
Posts (Atom)
